Pay in 4 interest-free payments of $5.06 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Ready to do this right
I am pre-diabetic and can really use these, said another
The race is no longer just about scienceits about scale, access, and economics
So lets look at IQVIAs observations on patient out-of-pocket costs from the 2024 report, with these observations: Out-of-pocket costs grew $6 bn in 2023 overall, with most increases in retail drugs consuming a larger share of all payers net spending than in 2022
US$ 25.74
US$ 21.86
US$ 21.98
US$ 22.34
US$ 24.75
US$ 26.25
